Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Schrödinger Community
NasdaqGS:SDGR Community
1
Narratives
written by author
0
Comments
on narratives written by author
18
Fair Values set
on narratives written by author
Create a narrative
Schrödinger
Popular
Undervalued
Overvalued
Community Investing Ideas
Schrödinger
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Partnerships With Novartis And Lilly Will Strengthen Future Prospects
Key Takeaways Expansion in software and partnerships with pharmaceutical giants is expected to boost revenue and margins significantly. New AI applications and clinical trial successes will enhance product offerings and stabilize revenue streams.
View narrative
US$30.80
FV
38.7% undervalued
intrinsic discount
24.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
SDGR
SDGR
Schrödinger
Your Fair Value
US$
Current Price
US$18.87
8.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-187m
467m
2015
2018
2021
2024
2025
2027
2030
Revenue US$467.4m
Earnings US$67.6m
Advanced
Set Fair Value